# Runway Growth Finance Corp.: financial statements, quarterly

RWAY · Nasdaq · CIK 1653384 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rway.md) · [Financials](/companies/rway/financials.md) · [Filings](/companies/rway/filings.md) · [Insiders](/companies/rway/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rway/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [10.4](/filings/0000950170-24-125299.md) | [10.4 d](/filings/0001193125-26-104117.md) | [10.9](/filings/0000950170-25-069164.md) | [10.9](/filings/0000950170-25-104963.md) | [11.4](/filings/0001193125-25-269547.md) | [11.1 d](/filings/0001193125-26-104117.md) | [10.3](/filings/0001193125-26-211877.md) | [11.8](/filings/0001193125-26-337968.md) | [10.6](/filings/0001193125-25-269547.md) | [10.0 d](/filings/0001193125-26-104117.md) | [10.5](/filings/0001193125-26-211877.md) | [13.0](/filings/0001193125-26-337968.md) |
| Net income | $m | [14.8](/filings/0000950170-24-125299.md) | [(4.8) d](/filings/0001193125-26-104117.md) | [12.0](/filings/0000950170-25-069164.md) | [8.3](/filings/0000950170-25-104963.md) | [25.0](/filings/0001193125-25-269547.md) | [28.2 d](/filings/0001193125-26-104117.md) | [1.9](/filings/0001193125-26-211877.md) | [16.8](/filings/0001193125-26-337968.md) | [8.0](/filings/0001193125-25-269547.md) | [7.4 d](/filings/0001193125-26-104117.md) | [(34.8)](/filings/0001193125-26-211877.md) | [27.2](/filings/0001193125-26-337968.md) |
| Diluted EPS | $ per share | [0.37](/filings/0000950170-24-125299.md) | not reported | [0.30](/filings/0000950170-25-069164.md) | [0.21](/filings/0000950170-25-104963.md) | [0.65](/filings/0001193125-25-269547.md) | not reported | [0.05](/filings/0001193125-26-211877.md) | [0.45](/filings/0001193125-26-337968.md) | [0.22](/filings/0001193125-25-269547.md) | not reported | [(0.96)](/filings/0001193125-26-211877.md) | [0.65](/filings/0001193125-26-337968.md) |
| Basic EPS | $ per share | [0.37](/filings/0000950170-24-125299.md) | not reported | [0.30](/filings/0000950170-25-069164.md) | [0.21](/filings/0000950170-25-104963.md) | [0.65](/filings/0001193125-25-269547.md) | not reported | [0.05](/filings/0001193125-26-211877.md) | [0.45](/filings/0001193125-26-337968.md) | [0.22](/filings/0001193125-25-269547.md) | not reported | [(0.96)](/filings/0001193125-26-211877.md) | [0.65](/filings/0001193125-26-337968.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.9](/filings/0000950170-23-060207.md) | [3.0](/filings/0000950170-25-042625.md) | [6.9](/filings/0000950170-24-054449.md) | [8.8](/filings/0000950170-24-093857.md) | [3.6](/filings/0000950170-24-125299.md) | [5.8](/filings/0001193125-26-104117.md) | [18.4](/filings/0000950170-25-069164.md) | [6.0](/filings/0000950170-25-104963.md) | [7.9](/filings/0001193125-25-269547.md) | [18.2](/filings/0001193125-26-337968.md) | [2.3](/filings/0001193125-26-211877.md) | [10.8](/filings/0001193125-26-337968.md) |
| Total assets | $m | [1,034](/filings/0000950170-23-060207.md) | [1,079](/filings/0000950170-25-042625.md) | [1,031](/filings/0000950170-24-054449.md) | [1,078](/filings/0000950170-24-093857.md) | [1,076](/filings/0000950170-24-125299.md) | [1,091](/filings/0001193125-26-104117.md) | [1,033](/filings/0000950170-25-069164.md) | [1,041](/filings/0000950170-25-104963.md) | [963](/filings/0001193125-25-269547.md) | [960](/filings/0001193125-26-337968.md) | [905](/filings/0001193125-26-211877.md) | [1,222](/filings/0001193125-26-337968.md) |
| Total liabilities | $m | [464](/filings/0000950170-23-060207.md) | [532](/filings/0000950170-25-042625.md) | [501](/filings/0000950170-24-054449.md) | [572](/filings/0000950170-24-093857.md) | [568](/filings/0000950170-24-125299.md) | [576](/filings/0001193125-26-104117.md) | [530](/filings/0000950170-25-069164.md) | [542](/filings/0000950170-25-104963.md) | [474](/filings/0001193125-25-269547.md) | [475](/filings/0001193125-26-337968.md) | [467](/filings/0001193125-26-211877.md) | [720](/filings/0001193125-26-337968.md) |
| Long-term debt | $m | [441](/filings/0000950170-23-060207.md) | [510](/filings/0000950170-25-042625.md) | [476](/filings/0000950170-24-054449.md) | [549](/filings/0000950170-24-093857.md) | [543](/filings/0000950170-24-125299.md) | [552](/filings/0001193125-26-104117.md) | [492](/filings/0000950170-25-069164.md) | [516](/filings/0000950170-25-104963.md) | [444](/filings/0001193125-25-269547.md) | [435](/filings/0001193125-26-337968.md) | [427](/filings/0001193125-26-211877.md) | [679](/filings/0001193125-26-337968.md) |
| Shareholders' equity | $m | [570](/filings/0000950170-24-125299.md) | [547](/filings/0001193125-26-104117.md) | [529](/filings/0000950170-25-104963.md) | [506](/filings/0001193125-25-269547.md) | [507](/filings/0001193125-25-269547.md) | [515](/filings/0001193125-26-337968.md) | [503](/filings/0001193125-26-337968.md) | [499](/filings/0001193125-26-337968.md) | [490](/filings/0001193125-25-269547.md) | [485](/filings/0001193125-26-337968.md) | [438](/filings/0001193125-26-337968.md) | [503](/filings/0001193125-26-337968.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [102 d](/filings/0000950170-24-125299.md) | [(61.6) d](/filings/0001193125-26-104117.md) | [68.6](/filings/0000950170-25-069164.md) | [(38.6) d](/filings/0000950170-25-104963.md) | [25.9 d](/filings/0001193125-25-269547.md) | [13.9 d](/filings/0001193125-26-104117.md) | [73.6](/filings/0001193125-26-211877.md) | [(0.3) d](/filings/0001193125-26-337968.md) | [92.4 d](/filings/0001193125-25-269547.md) | [20.6 d](/filings/0001193125-26-104117.md) | [5.9](/filings/0001193125-26-211877.md) | [(194) d](/filings/0001193125-26-337968.md) |
| Dividends paid | $m | [18.2 d](/filings/0000950170-24-125299.md) | [18.6 d](/filings/0001193125-26-104117.md) | [19.0](/filings/0000950170-25-069164.md) | [18.5 d](/filings/0000950170-25-104963.md) | [17.3 d](/filings/0001193125-25-269547.md) | [14.9 d](/filings/0001193125-26-104117.md) | not reported | not reported | [13.0 d](/filings/0001193125-25-269547.md) | [11.9 d](/filings/0001193125-26-104117.md) | [11.9](/filings/0001193125-26-211877.md) | [14.0 d](/filings/0001193125-26-337968.md) |
| Share repurchases | $m | not reported | not reported | [10.6](/filings/0000950170-25-069164.md) | [12.8 d](/filings/0000950170-25-104963.md) | [6.7 d](/filings/0001193125-25-269547.md) | [5.8 d](/filings/0001193125-26-104117.md) | not reported | not reported | [4.4 d](/filings/0001193125-25-269547.md) | [0.0 d](/filings/0001193125-26-104117.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.8](/filings/0000950170-23-060207.md) | [40.5](/filings/0000950170-24-054449.md) | [40.5](/filings/0000950170-24-093857.md) | [40.5](/filings/0000950170-24-125299.md) | [40.4](/filings/0000950170-25-069164.md) | [39.2](/filings/0000950170-25-104963.md) | [38.4](/filings/0001193125-25-269547.md) | [37.3](/filings/0001193125-26-211877.md) | [37.1](/filings/0001193125-26-337968.md) | [36.2](/filings/0001193125-25-269547.md) | [36.1](/filings/0001193125-26-211877.md) | [42.1](/filings/0001193125-26-337968.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,909,904 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337968.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.